article thumbnail

Photon-Counting CT Improves Coronary Artery Disease Assessment

DAIC

Coronary CT angiography for the suspected progression of known coronary artery disease in a 56-year-old female patient. mm (green outline) section thickness show the respective calcified plaque (arrowheads) and coronary stenosis (inset images). Curved multiplanar reconstructions with 0.6-mm

article thumbnail

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

DAIC

mtaschetta-millane Thu, 07/18/2024 - 10:00 July 18, 2024 — HeartFlow, Inc. , Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game changer as a clinician. Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment.

article thumbnail

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. 25, 2024 in the European Heart Journal Cardiovascular Imaging 1.

article thumbnail

Anthos Presents New Analysis from P2 AZALEA-TIMI 71 Study

DAIC

tim.hodson Mon, 11/18/2024 - 10:55 Nov. Patient Demographics: Patients on APT had a higher rate of coronary artery disease (70% vs. 42%), previous heart attacks (36% vs. 16%), and peripheral artery disease (15% vs. 11%). For more information, please visit anthostherapeutics.com.

article thumbnail

TCT Abstracts Use NCDR Data to Evaluate Site Volume and Failure to Rescue, Impact of CAD and Revascularization, More

American College of Cardiology

Several abstracts presented at TCT 2024, taking place Oct.

article thumbnail

Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024

DAIC

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

article thumbnail

GE Healthcare Launches New Cardiac PET tracer

DAIC

In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. link] ii Miller, R.